You Searched For "CRISPR Therapeutics" and got 20 results
Sort By:
1 min read
Intellia Therapeutics soars 63% after its gene-editing CRISPR therapy shows success in first human trials
Intellia partnered with Regeneron in 2016 to advance the CRISPR technology for in vivo therapeutic …
Matthew Fox
2 mins read
Cathie Wood's Ark ETFs are surging on big gains in CRISPR gene-editing stocks following the success of first human trials
Ark Invest's Cathie Wood said last year that the next "FANG" stocks would likely come from the gene…
Matthew Fox
2 mins read
Editas surges 50% as ARK founder Cathie Wood sees genomic stocks driving returns for the next 5 years
Behind Tesla, the third largest holding in the ARKK ETF is CRISPR Therapeutics, a gene editing comp…
Matthew Fox
2 mins read
Intellia CEO: There won't be a 'next CRISPR'
CRISPR-Cas9 is a tool that that's often described as a kind of genetic scissors. It allows scientis…
Lydia Ramsey
3 mins read
This startup wants to start using controversial CRISPR gene-editing technology in people by 2017
Many diseases, like Huntington's Disease and Cystic Fibrosis (CF), are caused by small tweaks, or m…
Lydia Ramsey
2 mins read
The FDA just approved the first gene editing therapy for sickle cell anemia, but it'll cost $2.2 million per person
The FDA approved the first ever gene therapies offering a "functional cure" for sickle cell anemia,…
Kenneth Niemeyer
2 mins read
Scientists may have discovered the first antidote to the deadliest mushroom known to humans
Scientists have been studying the death cap mushroom since the 1700s but only recently have discove…
Rupendra Brahambhatt
3 mins read
How a gene-editing breakthrough from a Harvard lab saved the life of a girl with leukemia
A 13-year-old girl became the first-ever patient to receive a base-editing therapy, and her leukemi…
Andrew Dunn
7 mins read
Wearables for plants, bacteria eating viruses, and 8 technologies in 2023 that can change the future
The World Economic Forum has announced ten breakthrough technologies set to change the world over t…
3 mins read
As gene-editing moves mainstream, a pioneer in the field is testing whether it could prevent Alzheimer's
Scientist David Liu has developed two ways to edit human DNA. He's testing whether they can be used…
Allison DeAngelis
5 mins read
See the presentations that cutting-edge biotech companies have used to raise millions from top investors
From 64x Bio to Faeth Therapeutics, here are the presentations that biotechs used to win over inves…
Leah Rosenbaum
2 mins read
Cathie Wood's flagship fund cashed out of Coinbase shares worth $25 million as the stock rose after bitcoin topped $57,000
Wood's Ark Innovation ETF sold more than 98,000 shares in the crypto exchange, worth about $25 mill…
Shalini Nagarajan
2 mins read
S&P 500, Nasdaq close at record highs as mega-cap tech spurs gains
US stocks jumped to new records to start the week. Facebook was handed a big win by a federal judge…
Isabelle Lee
4 mins read
A scientist who genetically edited babies was just sentenced to 3 years in prison. Here's how he did it and why scientists around the world are outraged.
The editing of human embryos raises a whole host of ethical questions that led to outrage from the …
Lydia Ramsey
2 mins read
A troubling link has been found between a cutting-edge gene-editing technology and cancer - and it's sending biotech stocks tumbling
The CEO of CRISPR Therapeutics said in a comment to STAT News that while the results are plausible,…
Charlotte Hu
2 mins read
Wall Street just freaked out about a potential hiccup to a revolutionary gene editing technology - but it's not as bad as it seems
CRISPR Therapeutics chief scientific officer Dr. Bill Lundberg told Business Insider that the hope …
Lydia Ramsey
4 mins read
A blockbuster gene-editing tool has been 'linked' to cancer - here's how worried you should be
Earlier this week, reports linking the blockbuster gene-editing tool CRISPR to cancer in two stud…
Erin Brodwin
5 mins read
A Peter Thiel-backed startup led by former SpaceX engineers just raised $110 million to make editing your DNA 'as accessible as vaccines'
Both of Synthego's kits are designed to make working with CRISPR easier. The first, called CRISPRev…
Erin Brodwin
3 mins read
Vertex shells out $950 million to acquire a company working on a diabetes cure
To try and address this pain point, pharma giant GSK spent $300 million to secure a four-year exclu…
Zachary Hendrickson,Zachary Hendrickson
1 min read
The FDA just put a pause on a cutting-edge gene editing trial that hadn't started yet - and the company's stock is dropping
Visit Markets Insider for constantly updated market quotes for individual stocks, ETFs, indices, c…